CMS certification 450051
Methodist Dallas Medical Center
1441 North Beckley Avenue, Dallas, TX 75203
Methodist Dallas Medical Center has a CMS overall rating of 3 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 20 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. Emergency patients spend a median of 3 h 49 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,126 completed surveys, 13% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | TX | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 360 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 49 min | 2 h 25 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 11 visits sampled | 4 h 37 min | 3 h 53 min | 4 h 17 min |
| Left before being seen Lower is better · 76,567 patients | 2% | 1% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 16 patients | 75% | 67% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 164 patients | 86% | 68% | 65% |
How Methodist Dallas Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Methodist Dallas Medical CenterThis hospital | 3/5 | 74% | 3 h 49 min | 2 better 1 worse |
| Baylor Scott and White Medical Center UptownSame city | Not rated | 74% | 1 h 42 min | No different |
| Dallas VA Medical Center (VA North Texas Healthcare System)Same city | 3/5 | 63% | — | 4 better 1 worse |
| White Rock Medical CenterSame city | 2/5 | — | 3 h 23 min | 1 worse |
| Baylor Scott & White Heart & Vascular Hospital - DallasSame city | 5/5 | 87% | — | 2 worse |
| Medical City Dallas HospitalSame city | 3/5 | 66% | 2 h 20 min | 2 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Dallas.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,740 cases | Too few cases | 3.8% | 3.9% |
| Heart attack 50 cases | Too few cases | 13.6% | 11.9% |
| Heart failure 128 cases | Too few cases | 9.9% | 11.1% |
| Pneumonia 99 cases | Too few cases | 13.5% | 15.2% |
| Stroke 373 cases | Too few cases | 11.5% | 11.9% |
| COPD 50 cases | Too few cases | 6.9% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.04 likely 0.73 – 1.35 | 1 |
| Deaths after a serious but treatable surgical complication 83 cases | No different | 207.49 per 1,000 likely 164.78 per 1,000 – 250.19 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 3,521 cases | No different | 0.34 per 1,000 likely 0 per 1,000 – 1.02 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 3,795 cases | No different | 0.17 per 1,000 likely 0 per 1,000 – 0.38 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 3,926 cases | No different | 0.27 per 1,000 likely 0.07 per 1,000 – 0.47 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,248 cases | No different | 3.74 per 1,000 likely 2.33 per 1,000 – 5.15 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 446 cases | No different | 1.77 per 1,000 likely 0.2 per 1,000 – 3.34 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 439 cases | No different | 10.29 per 1,000 likely 3.74 per 1,000 – 16.84 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,319 cases | No different | 4.58 per 1,000 likely 2.53 per 1,000 – 6.62 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 487 cases | No different | 6.44 per 1,000 likely 2.97 per 1,000 – 9.92 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 477 cases | No different | 1.51 per 1,000 likely 0.09 per 1,000 – 2.93 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,104 cases | No different | 1.01 per 1,000 likely 0.07 per 1,000 – 1.96 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.58 likely 0.27 – 1.1 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.58 likely 0.25 – 1.15 | 1 |
| Surgical site infections after colon surgery | No different | 1.44 likely 0.67 – 2.74 | 1 |
| MRSA bloodstream infections | No different | 0.88 likely 0.39 – 1.75 | 1 |
| C. diff intestinal infections | Better | 0.4 likely 0.25 – 0.59 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 171 cases | Too few cases | 13.3% | 14.4% |
| Readmitted after heart failure 483 cases | Too few cases | 19.6% | 21.3% |
| Readmitted after pneumonia 300 cases | Too few cases | 15.7% | 17.3% |
| Readmitted after COPD 174 cases | Too few cases | 18.4% | 20% |
| Readmitted after heart bypass surgery 43 cases | Too few cases | 9.9% | 11% |
| Days back in hospital after heart failure 145 cases | Too few cases | 23.3 days per 100 | — |
| Days back in hospital after pneumonia 109 cases | Too few cases | -7.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 376 cases | No different | 13.4 per 1,000 likely 10.1 per 1,000 – 17.8 per 1,000 | 13 per 1,000 |
| Unplanned visits after outpatient surgery 149 cases | No different | 1 likely 0.7 – 1.4 | — |
5 more measures had too few cases here to report.
Clinicians registered at this address
263 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 85 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 78 |
| Acute Care | 24 |
| Pharmacist | 18 |
| Physician Assistant | 18 |
| Emergency Medicine | 14 |
| Family | 10 |
| Diagnostic Radiology | 8 |
| Surgery | 8 |
| Obstetrics & Gynecology | 7 |
| Anatomic Pathology & Clinical Pathology | 6 |
| Pharmacotherapy | 6 |
| Neonatal-Perinatal Medicine | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.3M
- 2020 $2.7M
- 2021 $501,019
- 2022 $535,382
- 2023 $971,211
- 2024 $610,772
- 2025 $714,430
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $47,852 | 9 |
| Education | $10,850 | 5 |
| Space rental and facility fees | $6,000 | 2 |
| Debt forgiveness | $1,922 | 4 |
| Grants | $500 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Madrigal Pharmaceuticals | $303,887 | 145 |
| Taiho Oncology, INC. | $121,372 | 25 |
| Regeneron Pharmaceuticals, Inc. | $60,478 | 34 |
| Ipsen Bioscience Inc. | $46,889 | 59 |
| AngioDynamics, Inc. | $40,163 | 2 |
| Amgen Inc. | $26,083 | 1 |
| Vantive US Healthcare LLC | $25,324 | 5 |
| Novocure GmbH | $19,600 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A 52-WEEK, PHASE 3, OPEN-LABEL EXTENSION STUDY, WITH A DOUBLE-BLIND LEAD-IN, TO EVALUATE SAFETY AND BIOMARKERS OF RESMETIROM (MGL-3196) IN PATIENTS W… Madrigal Pharmaceuticals · NCT04951219 | $182,784 |
| Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusions or Rearrangements TAIHO ONCOLOGY, INC. | $121,372 |
| A PHASE 3 MULTINATIONAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY OF MGL3196 RESMETIROM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND F… Madrigal Pharmaceuticals · NCT03900429 | $121,103 |
| A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohep… Regeneron Pharmaceuticals, Inc. · NCT05519475 | $60,478 |
| Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab… Amgen Inc. | $26,083 |
| EF-44 Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemothera… Novocure GmbH | $26,000 |
| A Safety Evaluation of Prismocitrate 18 in Patients Receiving Continuous Renal Replacement Therapy (CRRT) Vantive US Healthcare LLC · NCT05399537 | $25,324 |
| A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in P… Ipsen Bioscience Inc. · NCT04526665 | $24,037 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Methodist Dallas Medical Center
Is Methodist Dallas Medical Center a good hospital?
Methodist Dallas Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 20 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Methodist Dallas Medical Center?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,126 completed HCAHPS surveys.
How long is the wait in the Methodist Dallas Medical Center emergency room?
Emergency patients spend a median of 3 h 49 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Methodist Dallas Medical Center receive money from drug and device companies?
Drug and device makers reported $714,430 in payments to Methodist Dallas Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.